2018 High Content Screening/Imaging Report Featuring Albany Molecular Research, Cell Signaling Technology, Danaher, GE Healthcare and Instrument Systems

News provided by

Nov 02, 2018, 09:30 ET

DUBLIN, Nov. 2, 2018 /PRNewswire/ --

The "High Content Screening/Imaging: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

The HCS/I market has significant potential due to rising demand from the drug discovery and molecular diagnosis segments. The capabilities and possibilities of HCS/I market growth increases with the growth of new technologies and technological advancements.

Emerging economies such as China, India, and South Korea are considered to be lucrative regions that are creating ample opportunities and scope for the market. Investments and funding from government and private ventures, research institutes and universities are supporting exploration into the potential of this market.

Growing drug discovery and molecular diagnostic and research through HCS/I will further boost the market in the near future. The global rise in infectious and noninfectious diseases, growing populations, technological advancements and innovation are other factors creating considerable demand for HCS/I.

The scope of this study encompasses the current market for drug discovery, molecular diagnostics, cancer research, personalized medicine and compound profiling. The report also includes regulatory aspects, recent developments, market projections, competitive landscapes and market share. Analyses of patents, clinical trials, innovations and opportunities, as well as the latest trends, are also discussed in the report. The report intends to explain the key trends of HCS/I technologies and applications in various geographies.

It also discusses the market determinants that act as motivating and restraining factors and provides insights to stakeholders and potential entrants. The report will be a key decision-making tool for government organizations, researchers, private players, angel investors, potential entrants and so forth.

The Report Includes:

An overview of the global markets for high content screening/imaging technologies
Analyses of global market trends, with data from 2017, estimated from 2018 and projections of compound annual growth rates (CAGRs) through 2023
Coverage of various microscope and imaging technologies in the industry
Detailed analysis of the technological advancement in cytometers, light sources, detectors/sensors and liquid handling instruments
Discussion of the various market motivators i.e. increasing R&D budget, advantages over manual and HTS, technological advancement, and automation
Company profiles of major players in the industry, including Albany Molecular Research, Inc. (AMRI), Cell Signaling Technology, Danaher Corp., GE Healthcare and Instrument Systems

Key Topics Covered:

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Intended Audience
Scope of Report
Information Sources
Research Methodology
Geographic Breakdown
Analyst's Credentials
Custom Research
Related Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Overview of Microscope and Imaging Technologies
Scanning Probe Microscopy
Scanning Electron Microscope
Transmission Electron Microscopy
Technological Advancements
Cytometers
Detectors/Sensors
Liquid Handling Instruments
Process Overview
High Content Screening
High Throughput Screening (HTS)
Market Dynamics
Key Factors Driving the Market
Limitations and Challenges
Market Opportunities

Chapter 4 Market Breakdown by Component

Instrument or Platform
Imaging Device
Cytometers
Plate Reader
Light Sources
Detectors/Sensors
Liquid Handling Instruments
Consumables (Reagents and Kits)
Software and Analytics
Store Image and Database Management Software by Thermo Fisher Scientific
OpenHiCAMM (Open Hi Content Acquisition for Manager) Software
Services
siRNA Screens

Chapter 5 Market Breakdown by End User

Academics
Laboratories and Pathology Centers
Companies (Biotechnology, Pharmaceutical and CRO)

Chapter 6 Market Breakdown by Application

Molecular Diagnosis
Oncology
Drug Discovery
Toxicity Studies
Acute Toxicity Studies
Subchronic Toxicity Studies
Chronic Toxicity
Neuroscience
Compound Profiling

Chapter 7 Market Breakdown by Region

North America
United States
Canada
Europe
The U.K.
Germany
France
Spain
Italy
Rest of Europe
MEA (Middle East and Africa)
Asia-Pacific
India
China
Japan
Rest of Asia-Pacific
Rest of the World

Chapter 8 Patent Review

Chapter 9 Industry Structure

Manufacturers/Suppliers
Thermo Fisher Scientific
GE Healthcare
GE Healthcare Patents, 2015-2017
Olympus Corp.
Molecular Devices
PerkinElmer, Inc.

Chapter 10 Company Profiles

Albany Molecular Research, Inc. (Amri)
Aurelia Bioscience Ltd.
Axxam Spa
Becton, Dickinson And Co.
Biotek Instruments, Inc.
Charles River
Corning, Inc.
Creative Biolabs
Curiox Biosystems, Inc.
Cytoo Sa
Danaher Corp.
De Novo Software
Definiens Ag
Discoverx Corp.
Essen Bioscience
Evotec Ag
Fluxion Biosciences
Ge Healthcare
Genedata Ag
Hudson Robotics, Inc.
Instrument Systems
Intellicyt Corp.
Lumencor, Inc.
Merck Millipore
Molecular Devices
Nemametrix, Inc.
Nikon Instruments, Inc.
Olympus Corp.
Perkinelmer, Inc.
Phenovista Biosciences Llc
Platypus Technologies
Sysmex Corp.
Tecan Group Ltd.
Thermo Fisher Scientific, Inc.
Thorlabs, Inc.
Vala Sciences, Inc.
Yokogawa Electric Corp.
Zeiss Group

For more information about this report visit https://www.researchandmarkets.com/research/dqsbb8/2018_high_content?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets